Wednesday, September 30 2026
12:10–12:55pm
Industry Theater
Advances in HIV Prevention in the US
Theater 1, Rooms C-D, Level 4
Description
Advances in HIV Prevention in the US will review the epidemiology and impact of HIV in the US and affected communities, outlining an available long acting injectable HIV PrEP option. This session will summarize key efficacy and safety data from clinical studies for an injectable PrEP option consistent with product labeling, information on how to recognize individuals who may need or want HIV PrEP, and considerations for incorporating PrEP into clinical practice.
Sponsored by
- Gilead Sciences, Inc.